Andres Männik
Impact in
- Virology top 5%
- HIV Research and Treatment
-
- Complement system in diseases
- interferon and immune responses
Papers in
- Immunology 14
- Complement system in diseases 7
-
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Mart Ustav (21 shared papers)Ene Ustav (6 shared papers)Andres Merits (3 shared papers)Age Utt (2 shared papers)Kadri Kangro (7 shared papers)Karen Vanhoorelbeke (7 shared papers)Aleksei Lulla (1 shared paper)Valeria Lulla (1 shared paper)
In The Last Decade
Andres Männik
30 papers receiving 470 citations
Peers
Comparison fields: 5 of 62
- Virology 75
- Immunology 177
- Infectious Diseases 103
- Epidemiology 171
- Nephrology 27
Countries citing papers authored by Andres Männik
This map shows the geographic impact of Andres Männik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andres Männik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andres Männik more than expected).
Fields of papers citing papers by Andres Männik
This network shows the impact of papers produced by Andres Männik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andres Männik. The network helps show where Andres Männik may publish in the future.
Co-authors
The 25 scholars most cited alongside Andres Männik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 65 | |
| 2 | 2013 | 45 | |
| 3 | 2009 | 40 | |
| 4 | Predominance of a rare type of HIV-1 in Estonia. | 2005 | 32 |
| 5 | 2019 | 26 | |
| 6 | 2014 | 25 | |
| 7 | 2006 | 24 | |
| 8 | 2017 | 23 | |
| 9 | 2015 | 22 | |
| 10 | 2018 | 22 | |
| 11 | 2002 | 21 | |
| 12 | 2019 | 20 | |
| 13 | 2021 | 16 | |
| 14 | 2016 | 14 | |
| 15 | 2021 | 14 | |
| 16 | 2020 | 12 | |
| 17 | 2021 | 11 | |
| 18 | 2021 | 9 | |
| 19 | 2015 | 9 | |
| 20 | 2015 | 9 |
About Andres Männik
Andres Männik is a scholar working on Immunology, Molecular Biology, Epidemiology, Infectious Diseases and Virology, having authored 31 papers that have together received 494 indexed citations. Recurring topics across this work include Complement system in diseases (7 papers), Cervical Cancer and HPV Research (6 papers), Viral-associated cancers and disorders (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Virus-based gene therapy research (4 papers), Viral Infections and Vectors (3 papers), HIV Research and Treatment (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Virology (75 citations), Immunology (177 citations), Infectious Diseases (103 citations), Epidemiology (171 citations) and Nephrology (27 citations). Andres Männik has collaborated with scholars based in Estonia, France and Belgium. Frequent co-authors include Mart Ustav, Ene Ustav, Andres Merits, Age Utt, Kadri Kangro, Karen Vanhoorelbeke, Aleksei Lulla, Valeria Lulla, Märt Toots and Kai Krohn. Their work appears in journals such as Journal of Virology, PLoS ONE, Journal of Thrombosis and Haemostasis, PLoS Pathogens and AIDS Research and Human Retroviruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.